Sabra Healthcare REIT Inc (NASDAQ: SBRA) on November 20, 2023, started off the session at the price of $14.25, soaring 1.89% from the previous trading day. During the day, the shares moved up to $14.59 and dropped to $14.195 before settling in for the closing price of $14.30. Within the past 52 weeks, SBRA’s price has moved between $10.08 and $14.82.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
A company in the Real Estate sector has jumped its sales by 10.85% annually for the last half of the decade. The company achieved an average annual earnings per share of 172.06%. With a float of $227.98 million, this company’s outstanding shares have now reached $231.01 million.
In an organization with 42 employees, it is important to assess its efficiency. In terms of profitability, gross margin is +43.31, operating margin of +39.26, and the pretax margin is -13.56.
Sabra Healthcare REIT Inc (SBRA) Insider and Institutional Ownership
Observing investor behavior towards REIT – Healthcare Facilities industry stocks is more important than anything else. The insider ownership of Sabra Healthcare REIT Inc is 1.40%, while institutional ownership is 99.28%. The most recent insider transaction that took place on Sep 01, was worth 24,591. In this transaction Executive VP, CFO & Secretary of this company bought 1,947 shares at a rate of $12.63, taking the stock ownership to the 183,218 shares.
Sabra Healthcare REIT Inc (SBRA) Latest Financial update
As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.07 earnings per share (EPS) for the period falling under the consensus outlook (set at $0.13) by -$0.2. This company achieved a net margin of -12.55 while generating a return on equity of -2.41. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 172.06% per share during the next fiscal year.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) Trading Performance Indicators
Sabra Healthcare REIT Inc (SBRA) is currently performing well based on its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.29. Likewise, its price to free cash flow for the trailing twelve months is 11.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.38, a number that is poised to hit 0.14 in the next quarter and is forecasted to reach 0.61 in one year’s time.
Technical Analysis of Sabra Healthcare REIT Inc (SBRA)
Let’s dig in a bit further. During the last 5-days, its volume was 2.89 million. That was better than the volume of 2.25 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 66.88%. Additionally, its Average True Range was 0.41.
During the past 100 days, Sabra Healthcare REIT Inc’s (SBRA) raw stochastic average was set at 92.30%, which indicates a significant increase from 82.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.74% in the past 14 days, which was higher than the 25.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.95, while its 200-day Moving Average is $12.41. However, in the short run, Sabra Healthcare REIT Inc’s stock first resistance to watch stands at $14.71. Second resistance stands at $14.85. The third major resistance level sits at $15.10. If the price goes on to break the first support level at $14.31, it is likely to go to the next support level at $14.06. The third support level lies at $13.92 if the price breaches the second support level.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) Key Stats
Market capitalization of the company is 3.37 billion based on 231,220K outstanding shares. Right now, sales total 624,810 K and income totals -77,610 K. The company made 161,630 K in profit during its latest quarter, and -15,100 K in sales during its previous quarter.